For example, mutations in the KRAS gene, which is crucial in the RAS/RAF/MAPK signaling pathway, are common in several cancers, such as colorectal cancer and non-small cell lung cancer (NSCLC). This evidence concerns the gene RAF1 and non-small cell lung carcinoma.